Position in DNLI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$457,250
+$412,905 QoQ
Shares Held
17,778
+561.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#153
of 290 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026State of Wyoming holds $40,938,454 across 171 Biotechnology names. DNLI ranks #24 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
35,525 | $4,027,114 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,698 | $2,478,669 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
4,767 | $1,771,750 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
9,446 | $1,769,046 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
11,780 | $1,350,812 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,410 | $1,294,049 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
48,794 | $1,234,488 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
2,768 | $926,698 |
All Filings in DNLI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $457,250 | 17,778 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $44,345 | 2,686 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $31,276 | 2,154 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $29,365 | 2,099 | Shares | Sole | 2025-08-19 | |
| 2022-06-30 | $235 | 8 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $36,480 | 1,134 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,215 | 386 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||